Holen Sie sich die Stockscreener-App
353.17
6.01%
20.02
Vorhandelsmarkt:
347.26
-5.91
-1.67%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LRCX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$333.15
Offen:
$365.13
24-Stunden-Volumen:
12.08M
Relative Volume:
1.11
Marktkapitalisierung:
$441.66B
Einnahmen:
$21.68B
Nettoeinkommen (Verlust:
$6.71B
KGV:
66.66
EPS:
5.298
Netto-Cashflow:
$6.00B
1W Leistung:
+0.50%
1M Leistung:
+7.95%
6M Leistung:
+61.74%
1J Leistung:
+253.84%
1-Tages-Spanne:
$350.06
$369.95
1-Wochen-Bereich:
$313.10
$369.95
52-Wochen-Spanne:
$90.73
$438.50
Lam Research Corp Stock (LRCX) Company Profile
Firmenname
Lam Research Corp
Sektor
Telefon
(510) 659-0200
Adresse
4650 CUSHING BLVD, FREMONT, CA
Compare LRCX vs ASML, AMAT, KLAC, TER
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LRCX
Lam Research Corp
|
353.17 | 441.66B | 21.68B | 6.71B | 6.00B | 5.298 |
ASML
Asml Holding Nv
|
1,804.25 | 695.39B | 39.08B | 11.61B | 9.94B | 30.00 |
AMAT
Applied Materials Inc
|
588.66 | 467.37B | 29.02B | 8.51B | 5.34B | 10.64 |
KLAC
Kla Corp
|
229.52 | 299.82B | 13.09B | 4.67B | 4.01B | 35.37 |
TER
Teradyne Inc
|
362.75 | 56.79B | 3.79B | 854.06M | 553.18M | 5.4031 |
Lam Research Corp Stock (LRCX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-02 | Herabstufung | Erste Group | Buy → Hold |
| 2026-01-29 | Hochstufung | Summit Insights | Hold → Buy |
| 2026-01-29 | Bestätigt | TD Cowen | Buy |
| 2026-01-15 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-01-15 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-10-23 | Bestätigt | TD Cowen | Buy |
| 2025-09-30 | Eingeleitet | HSBC Securities | Hold |
| 2025-09-29 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-09-23 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-09-22 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2025-09-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-08-14 | Fortgesetzt | Erste Group | Buy |
| 2025-07-31 | Herabstufung | Summit Insights | Buy → Hold |
| 2025-07-31 | Bestätigt | TD Cowen | Buy |
| 2025-07-10 | Eingeleitet | Goldman | Buy |
| 2025-04-24 | Bestätigt | TD Cowen | Buy |
| 2025-03-20 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-02-20 | Hochstufung | Susquehanna | Neutral → Positive |
| 2025-01-30 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-01-30 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-17 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-01-15 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-12-17 | Eingeleitet | Cleveland Research | Neutral |
| 2024-08-01 | Bestätigt | TD Cowen | Buy |
| 2024-05-13 | Eingeleitet | Jefferies | Buy |
| 2024-04-25 | Bestätigt | TD Cowen | Buy |
| 2024-04-19 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2024-04-18 | Bestätigt | Needham | Buy |
| 2024-04-16 | Eingeleitet | Evercore ISI | Outperform |
| 2024-04-11 | Fortgesetzt | Deutsche Bank | Hold |
| 2024-01-25 | Bestätigt | TD Cowen | Outperform |
| 2024-01-23 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-12-12 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-22 | Eingeleitet | Redburn Atlantic | Buy |
| 2023-10-17 | Eingeleitet | Raymond James | Outperform |
| 2023-10-13 | Hochstufung | Needham | Hold → Buy |
| 2023-09-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-07-24 | Bestätigt | Mizuho | Buy |
| 2023-07-24 | Hochstufung | Stifel | Hold → Buy |
| 2023-04-20 | Bestätigt | Berenberg | Buy |
| 2023-04-20 | Bestätigt | Evercore ISI | Outperform |
| 2023-04-20 | Bestätigt | JP Morgan | Overweight |
| 2023-04-20 | Bestätigt | Jefferies | Buy |
| 2023-04-20 | Bestätigt | Mizuho | Buy |
| 2023-04-20 | Bestätigt | Stifel | Hold |
| 2023-04-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2023-03-13 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-01-18 | Fortgesetzt | Stifel | Hold |
| 2022-12-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-10-20 | Bestätigt | B. Riley Securities | Neutral |
| 2022-10-20 | Bestätigt | BofA Securities | Buy |
| 2022-10-20 | Bestätigt | DA Davidson | Neutral |
| 2022-10-20 | Bestätigt | Evercore ISI | Outperform |
| 2022-10-20 | Bestätigt | JP Morgan | Overweight |
| 2022-10-20 | Bestätigt | Jefferies | Buy |
| 2022-10-20 | Hochstufung | Summit Insights | Hold → Buy |
| 2022-10-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-07-25 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-06-15 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2022-01-27 | Bestätigt | Barclays | Overweight |
| 2022-01-27 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-27 | Bestätigt | Evercore ISI | Outperform |
| 2022-01-27 | Bestätigt | Stifel | Buy |
| 2022-01-27 | Bestätigt | Susquehanna | Neutral |
| 2022-01-27 | Bestätigt | UBS | Buy |
| 2022-01-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-01-12 | Bestätigt | Barclays | Overweight |
| 2022-01-10 | Bestätigt | BofA Securities | Buy |
| 2022-01-05 | Fortgesetzt | Jefferies | Buy |
| 2021-12-15 | Bestätigt | Deutsche Bank | Hold |
| 2021-10-21 | Bestätigt | B. Riley Securities | Buy |
| 2021-10-21 | Herabstufung | Summit Insights | Buy → Hold |
| 2021-10-15 | Eingeleitet | Piper Sandler | Neutral |
| 2021-09-14 | Herabstufung | Susquehanna | Positive → Neutral |
| 2021-09-07 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2021-07-29 | Bestätigt | Mizuho | Buy |
| 2021-07-29 | Bestätigt | Stifel | Buy |
| 2021-07-29 | Bestätigt | UBS | Buy |
| 2021-07-29 | Bestätigt | Wells Fargo | Equal Weight |
| 2021-03-31 | Eingeleitet | Bernstein | Outperform |
| 2021-01-28 | Bestätigt | Cowen | Outperform |
| 2021-01-08 | Herabstufung | Needham | Buy → Hold |
| 2020-12-17 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2020-10-22 | Bestätigt | Goldman | Buy |
| 2020-10-22 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-10-22 | Bestätigt | Mizuho | Buy |
| 2020-10-22 | Bestätigt | Morgan Stanley | Overweight |
| 2020-10-22 | Bestätigt | RBC Capital Mkts | Outperform |
| 2020-10-22 | Bestätigt | Stifel | Buy |
| 2020-10-22 | Bestätigt | UBS | Buy |
| 2020-09-21 | Hochstufung | Stifel | Hold → Buy |
| 2020-07-30 | Bestätigt | Cowen | Outperform |
| 2020-07-21 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2020-06-22 | Herabstufung | Stifel | Buy → Hold |
| 2020-06-16 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-26 | Eingeleitet | Barclays | Overweight |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-04-08 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2020-04-03 | Hochstufung | Nomura | Neutral → Buy |
| 2020-04-02 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-03-27 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-03-27 | Hochstufung | UBS | Sell → Buy |
Alle ansehen
Lam Research Corp Aktie (LRCX) Neueste Nachrichten
Is Lam Research Corp (LRCX) Overvalued After 6.0% Rally? GF Valu - GuruFocus
SanDisk, Lam Research among market cap stock movers on Thursday - Investing.com
SanDisk, Lam Research among market cap stock movers on Thursday By Investing.com - Investing.com UK
Morgan Stanley Raises its Price Target on Lam Research (LRCX) - Insider Monkey
Why Is Lam Research Stock Soaring Thursday? - Benzinga
Deutsche Bank Adjusts Price Target on Lam Research to $385 From $325 - Moomoo
Lam Research Corp Stock (LRCX) Moved Up by 6.35% on Jul 9: Key Drivers Unveiled - TradingKey
Mizuho raises Lam Research stock price target on AI chip demand - Investing.com
Aehr Test Systems, Lam Research, Applied Materials And Other Big Stocks Moving Higher On Thursday - Benzinga
Why is Lam Research stock surging today? - Investing.com
Lam Research stock reflects semiconductor cycle as investors weigh memory recovery and AI demand - Ad-hoc-news.de
Mizuho Adjusts Price Target on Lam Research to $400 From $380 - Moomoo
Resona Asset Management Co. Ltd. Purchases 5,286 Shares of Lam Research Corporation $LRCX - MarketBeat
Munich Reinsurance Co Stock Corp in Munich Decreases Stake in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation Shs Thailand Depositary Receipts Repr 1 Sh Financial Statements – SET:LRCX19 - TradingView
AXS Dynamic Opportunity Fund's Lam Research Corp(LRCX) Holding History - GuruFocus
Lam Research to host June quarter financial conference call - scanx.trade
Lam Research Corporation Announces June Quarter Financial Conference Call - Yahoo Finance
United Asset Strategies Inc. Acquires Shares of 3,596 Lam Research Corporation $LRCX - MarketBeat
FOCUSED DYNAMIC GROWTH FUND's Lam Research Corp(LRCX) Holding History - GuruFocus
Lam Research (LRCX) Dips More Than Broader Market: What You Should Know - Yahoo Finance
Lam Research (NASDAQ:LRCX) Shares Down 6.9%Here's Why - MarketBeat
Lam Research Corp (LRCX) Shares Fall 6.9% -- GF Value Says Still Overvalued - GuruFocus
Lam Research Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Why Lam Research (LRCX) Stock Is Down Today - Quiver Quantitative
Lam Research Corp outlook and business context for investors - AD HOC NEWS
The Nasdaq's Rough Day: When Good News Is Bad News for Market Indexes - The Motley Fool
Lam Research Corp Stock (LRCX) Moved Down by 7.54% on Jul 7: What Signal Does It Send? - TradingKey
Why is Lam Research stock tumbling today? By Investing.com - Investing.com South Africa
Why is Lam Research stock tumbling today? - Investing.com
LRCX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
LRCXLam Research Corp Options - Finviz
Lam Research CEO Archer reports $11.7m in stock sales By Investing.com - Investing.com South Africa
Form 4 Lam Research Corp For: 6 July By Investing.com - Investing.com Nigeria
Lam Research CEO Archer reports $11.7m in stock sales - Investing.com
Is Lam Research (LRCX) One of the Best Stocks on the Rise to Invest In? - Insider Monkey
Susquehanna Lifts PT on Lam Research (LRCX) – Here’s Why - Insider Monkey
LAM Research (LRCX) CEO Archer exercises options and sells 30,000 shares under 10b5-1 plan - Stock Titan
‘Logic’ Tells Me to Buy Lam Research, but Not Yet - TheStreet Pro
Goldman Sachs Adjusts Lam Research Price Target to $380 From $290 - Moomoo
What You Need to Know Ahead of Lam Research's Earnings Release - Barchart.com
2 Chip Stocks Driving Today's Rally With Lofty Bull Notes - Schaeffer's Investment Research
Why is Lam Research stock surging today? By Investing.com - Investing.com South Africa
Morgan Stanley Adjusts Price Target on Lam Research to $404 From $331 - Moomoo
Koshinski Asset Management Inc. Makes New $1.25 Million Investment in Lam Research Corporation $LRCX - MarketBeat
Lam Research (LRCX) Stock Falls As AI Demand Fears Clash With Company Guidance - Yahoo Finance
CARRET ASSET MANAGEMENT, LLC's Lam Research Corp(LRCX) Holding History - GuruFocus
Jim Cramer Says He Kept Waiting for Breaks in Stocks Like Lam Research Which Never Came - Insider Monkey
Lam Research Corporation $LRCX Shares Bought by Boston Trust Walden Corp - MarketBeat
Vltava Fund: Lam Research (LRCX) Is Overvalued - Yahoo Finance
Lam Research Corp at Morgan Stanley Technology, Media & Telecom Conference Transcript - GuruFocus
Finanzdaten der Lam Research Corp-Aktie (LRCX)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):